HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Daniel J Drucker Selected Research
Daniel J Drucker Research Topics
Disease
60
Type 2 Diabetes Mellitus (MODY)
01/2022 - 01/2002
38
Obesity
01/2022 - 05/2006
38
Body Weight (Weight, Body)
01/2022 - 03/2003
24
Insulin Resistance
01/2019 - 10/2003
22
Inflammation (Inflammations)
01/2021 - 05/2006
17
Weight Loss (Weight Reduction)
01/2021 - 11/2006
13
Hyperglycemia
11/2018 - 02/2003
10
Hypoglycemia (Reactive Hypoglycemia)
04/2019 - 10/2003
9
Weight Gain
01/2022 - 11/2006
9
Neoplasms (Cancer)
04/2019 - 07/2002
8
Myocardial Infarction
11/2021 - 04/2009
8
Glucose Intolerance
01/2018 - 02/2004
6
Atherosclerosis
11/2021 - 01/2013
6
Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2021 - 11/2007
6
Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 07/2009
5
Ischemia
10/2017 - 05/2008
5
Hyperplasia
04/2013 - 04/2010
4
Fibrosis (Cirrhosis)
01/2020 - 01/2013
4
Diabetes Mellitus
08/2017 - 01/2002
3
Nausea
01/2021 - 01/2002
3
Albuminuria
01/2020 - 03/2014
3
Hypertension (High Blood Pressure)
01/2020 - 10/2016
3
Short Bowel Syndrome
04/2019 - 01/2014
3
Pancreatitis
01/2018 - 09/2009
3
medullary Thyroid cancer
01/2018 - 07/2011
3
Infarction (Infarctions)
02/2015 - 04/2009
3
Anorexia
04/2013 - 01/2005
2
Stroke (Strokes)
11/2021 - 01/2018
2
Vomiting
01/2021 - 01/2002
2
Metabolic Diseases (Metabolic Disease)
01/2021 - 01/2017
2
Intestinal Failure
01/2020 - 01/2020
2
Cardiomegaly (Heart Hypertrophy)
01/2020 - 03/2016
2
Pancreatic Neoplasms (Pancreatic Cancer)
01/2018 - 05/2006
2
Vascular System Injuries
01/2018 - 12/2016
2
Heart Diseases (Heart Disease)
11/2017 - 07/2009
2
Hypertrophy
02/2015 - 01/2013
2
Necrosis
01/2013 - 01/2003
2
Colitis
06/2012 - 02/2002
2
Enteritis
03/2012 - 02/2002
2
Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
02/2012 - 12/2004
Drug/Important Bio-Agent (IBA)
62
Glucose (Dextrose)
FDA Link
Generic
01/2022 - 01/2002
61
Glucagon-Like Peptide 1 (GLP 1)
IBA
01/2022 - 01/2002
32
Glucagon-Like Peptide-1 Receptor
IBA
11/2021 - 09/2005
25
Glucagon (Glukagon)
FDA Link
01/2022 - 10/2003
25
Incretins
IBA
01/2019 - 01/2002
18
Insulin (Novolin)
FDA Link
01/2022 - 10/2003
15
Liraglutide
FDA Link
01/2022 - 11/2006
15
Peptides (Polypeptides)
IBA
01/2021 - 01/2002
13
Dipeptidyl-Peptidase IV Inhibitors
IBA
01/2018 - 01/2002
12
Hormones (Hormone)
IBA
01/2021 - 07/2002
11
Glucagon-Like Peptide-1 Receptor Agonists
IBA
01/2022 - 01/2002
11
Exenatide (Byetta)
FDA Link
03/2015 - 01/2003
8
Glucagon Receptors (Glucagon Receptor)
IBA
11/2018 - 10/2005
8
Blood Glucose (Blood Sugar)
IBA
04/2013 - 01/2002
7
Sitagliptin Phosphate (Januvia)
FDA Link
01/2020 - 11/2006
6
semaglutide
IBA
01/2022 - 08/2017
6
gastric inhibitory polypeptide receptor
IBA
01/2022 - 01/2012
6
Proteins (Proteins, Gene)
FDA Link
01/2020 - 10/2008
6
Lipids
IBA
01/2020 - 06/2010
6
Glucagon-Like Peptides (Enteroglucagon)
IBA
01/2020 - 07/2002
5
Leptin
IBA
01/2021 - 01/2008
5
Pharmaceutical Preparations
IBA
01/2021 - 02/2002
5
Metformin (Glucophage)
FDA Link
Generic
01/2020 - 01/2002
5
Enzymes
IBA
01/2020 - 05/2007
5
Biological Products
IBA
10/2019 - 01/2003
5
Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)
IBA
10/2017 - 01/2002
4
Triglycerides (Triacylglycerol)
IBA
01/2021 - 04/2008
4
Biomarkers (Surrogate Marker)
IBA
01/2021 - 11/2018
4
Messenger RNA (mRNA)
IBA
10/2019 - 10/2003
4
Proglucagon (Glucagon Precursors)
IBA
04/2019 - 07/2002
4
Streptozocin (Streptozotocin)
FDA Link
11/2015 - 11/2008
3
Calcitonin (Calcitonin, Eel)
FDA Link
Generic
01/2020 - 02/2008
3
Therapeutic Uses
IBA
10/2019 - 02/2002
3
Cytokines
IBA
10/2019 - 01/2003
3
fibroblast growth factor 21
IBA
01/2018 - 01/2016
3
Hypoglycemic Agents (Hypoglycemics)
IBA
01/2018 - 09/2009
3
Dextran Sulfate
IBA
06/2012 - 02/2002
3
Glucagon-Like Peptide-2 Receptor
IBA
09/2010 - 10/2005
2
Interleukin-6 (Interleukin 6)
IBA
10/2019 - 10/2011
2
teduglutide
IBA
04/2019 - 02/2015
2
Sugars
IBA
01/2019 - 04/2013
2
Lipoproteins (Lipoprotein)
IBA
08/2017 - 09/2009
2
Peptide Hormones (Polypeptide Hormones)
IBA
12/2016 - 07/2013
2
Cholesterol
IBA
10/2016 - 01/2015
2
Sodium
IBA
10/2016 - 01/2015
2
Doxorubicin (Adriamycin)
FDA Link
Generic
03/2016 - 08/2014
2
salicylhydroxamic acid (SHAM)
IBA
03/2014 - 02/2003
2
Gastrins
IBA
07/2013 - 10/2003
2
Gastric Inhibitory Polypeptide (Glucose Dependent Insulinotropic Peptide)
IBA
07/2013 - 01/2002
2
NF-kappa B (NF-kB)
IBA
01/2013 - 05/2006
2
Thiazolidinediones
IBA
02/2011 - 01/2006
2
glycogen synthase kinase 3 alpha
IBA
10/2008 - 10/2007
2
Glycogen Synthase Kinase 3
IBA
10/2008 - 10/2007
Therapy/Procedure
28
Therapeutics
01/2022 - 01/2002
6
Glycemic Control
01/2021 - 06/2010
5
Bariatric Surgery
01/2022 - 07/2013
3
Drug Therapy (Chemotherapy)
01/2022 - 02/2002
3
Injections
01/2021 - 11/2006
2
Ligation
02/2015 - 04/2010
2
Parenteral Nutrition
02/2015 - 01/2014